Circulating Biomarkers in Thyroid Cancer

Preview this chapter:

Circulating Biomarkers in Thyroid Cancer, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815040463/chap4-1.gif

Thyroid cancer is the most important endocrine cancer with increasing incidence. While thyroid cancers, especially papillary thyroid cancers, are known to exhibit generally a favorable outcome with excellent survival rates, some thyroid cancers are more aggressive with a poor prognosis. Several different biomarkers have been introduced for the diagnosis of disease, identification of tumor load, assessment of therapy response, and the detection of recurrence during follow-up of the thyroid cancer patients. This chapter gives a brief overview of the circulating biomarkers used in thyroid cancer patients.